Sirolimus-based product as a next-generation therapeutic for the treatment/prevention of wet AMD and the treatment of diabetic macular edema.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of MacuSight plus 5589 other startups.

Start Free 7 Day Trial Now

Learn More About MacuSight

Technology/product details

Competing Startups


Companies We Work With